Trade Summary

2 months ago, Debbane Raymond, serving as Dir at Lexicon Pharmaceuticals, Inc. (LXRX), purchased 268,497 shares at $1.31 per share, for a total transaction value of $352,889.00. Following this transaction, Debbane Raymond now holds 51,408,909 shares of LXRX.

This purchase represents a 1.00% increase in Debbane Raymond's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, February 13, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 18, 2026, 5 days after the trade was made.

Lexicon Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.